Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel palladium-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN116253692A enables efficient, metal-free synthesis of trifluoromethyl triazines under ambient conditions, offering significant cost savings and supply chain reliability for pharmaceutical intermediates.
Patent CN107522606B enables efficient synthesis of 1,4-ketoaldehyde with mild conditions and copper catalysis, offering supply chain reliability and cost reduction for pharmaceutical intermediates.
This patent reveals a novel Pd-catalyzed route for 2-trifluoromethyl quinazolinone, offering high yields and broad substrate scope, enabling cost reduction in pharmaceutical intermediate manufacturing.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
Patent CN115611739B enables high-purity benpropenoic acid intermediate synthesis with simplified steps, safer reagents, and scalable production for global pharmaceutical supply chains.
Patent CN115260080B enables efficient one-step synthesis of indole-3-carboxamide with high substrate tolerance, offering scalable production and cost reduction for pharmaceutical intermediates.
This patent reveals a novel, iron-catalyzed route for 2-trifluoromethyl quinazolinone, offering scalable synthesis with high purity and reduced manufacturing costs for pharmaceutical applications.
This patent introduces a novel palladium-catalyzed carbonylation route for pyrone derivatives using nitroarenes and molybdenum carbonyl, enabling scalable, cost-efficient synthesis with broad substrate tolerance for pharmaceutical intermediates.
Patent CN118271227A enables scalable, mild synthesis of 4-formylpyrrole derivatives via silver catalysis, offering high yield and simplified purification for pharmaceutical supply chains.
This patent reveals a novel carbonylation method for thioester synthesis, eliminating malodorous thiols and enabling scalable, cost-effective production for pharmaceutical intermediates.
Patent CN120398774A enables high-yield, mild-condition synthesis of C-3 alkylated quinoxalinones, offering scalable routes with simplified purification for pharmaceutical supply chains.
A novel Pd-catalyzed aminocarbonylation method enables efficient, scalable synthesis of 3-arylquinolinone derivatives, offering significant cost savings and supply chain reliability for pharmaceutical intermediates.
Patent CN113880781B enables scalable, mild synthesis of trifluoromethyl triazoles using glucose, offering supply chain resilience and cost reduction for pharmaceutical intermediates.
This patent reveals a novel visible-light-driven iron-catalyzed method for aryl benzyl sulfide synthesis, offering enhanced substrate scope and milder conditions for reliable pharmaceutical intermediate production.
This patent reveals a streamlined Pd-catalyzed carbonylation for 3-benzylidene-2,3-dihydroquinolone, offering enhanced scalability and cost reduction in pharmaceutical intermediate manufacturing.
Novel rhodium-catalyzed method enables scalable, high-purity trifluoromethyl indole synthesis with simplified purification and cost reduction in pharmaceutical manufacturing.
Patent CN119306765B enables high-yield asymmetric synthesis of florfenicol and chloramphenicol intermediates with superior stereoselectivity and scalable catalytic efficiency.
Patent CN109265385B details a novel, scalable synthesis for chiral diphenyl prolinol, offering high optical purity and simplified process for cost reduction in pharmaceutical manufacturing.
Patent CN117164506B enables scalable, high-yield synthesis of indeno[1,2-b]indole-10(5H)-one with simplified purification, offering cost reduction and supply chain reliability for pharmaceutical intermediates.